Experimental cerebrovascular disorders: effects of papaverine and theophylline.
D000241:Adenosine / Q000378:metabolism; D000818:Animals; D002556:Cerebrospinal Fluid Proteins / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D000242:Cyclic AMP / Q000134:cerebrospinal fluid; D004353:Drug Evaluation, Preclinical; D005260:Female; D008297:Male; D010208:Papaverine / Q000627:therapeutic use*; D011817:Rabbits; D013806:Theophylline / Q000627:therapeutic use*
D002556:Cerebrospinal Fluid Proteins; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D000241:Adenosine